![]() |
|||||||||
|
|
|||||||||
|
SCIENTIFIC ADVISORY BOARD
|
Halotherapy for Sports Performance
Enhancement
When you're an athlete, as you know
every advantage counts. Halotherapy for Sports Performance Enhancement
can help you get that edge over the competition.
Pharmacologic therapy: ask your doctor Nonpharmacologic
therapy: Hypertonic saline aerosol inhalation treatment is clinically proven:
Thus, integrating Halotherapy with other nonpharmacologic therapies can lead to better lung function and improved performance as well as both prevention and treatment of respiratory conditions among athletes.
The program involves:
Sports Performance Enhancement program can help:
Respiratory muscle training can help:
Thus Sports Performance Enhancement program can improve pulmonary function, which in turn leads to a better performance in sports. Why us:
General Information Typically, our program is based on 15 sessions,
either 5 days per week for 3 weeks or 3 days per week for 5 weeks. If
needed, we can modify this format to meet the needs of the athlete. We welcome questions and are happy to give tours of the facility and provide complimentary treatment for educational purposes. For more information, please call the Speleotherapy Clinic at (416)-739-7777. References: Athletes who participate in environments in which there may be environmental pollutants are at increased risk for the development of EIB (Exercise-Induced Bronchoconstriction). Chlorine compounds in swimming pools and chemicals related to ice-resurfacing machinery in ice rinks may put certain populations of athletes at additional risk. Particulate matter and gases such as carbon monoxide and nitrogen dioxide, which are abundant in indoor ice arenas, and chlorine from swimming pools may act as allergic "triggers" and may exacerbate bronchospasm in athletes who are predisposed to EIB. Helenius and Haahtela showed a 96-fold greater risk of asthma in atopic swimmers when compared to nonatopic control subjects when atopy and swimming were included in multivariate statistical analysis. Leuppi et al found a 35% incidence of airway hyperresponsiveness in a group of ice-hockey players. In addition, figure skaters have been shown to have a high incidence of EIB.(1) Although athletes who compete in high-ventilation or endurance sports are more likely to experiences symptoms of EIB than those who participate in low-ventilation sports, EIB can occur in any setting. It is especially prevalent in endurance events such as cross-country skiing, swimming, and long-distance running in which ventilation is increased for long periods of time during training and competition, allowing for relatively more evaporative water loss and subsequent airway narrowing. There is also increased prevalence of EIB in winter sports athletes, which is thought to be due in part to the increased cooling of airways and the relative increase in reactive hyperemia in the pulmonary vasculature. It is important for athletes, coaches, and trainers supervising athletes in these "higher risk" sports to be aware of the increased incidence of EIB in these populations of athletes.(1) The prevalence rates of bronchospasm related to exercise in athletes range from 11 to 50%, and up to 90% of subjects with asthma will have EIB. Wilber at al found that 18 to 26% of Olympic winter sport athletes and 50% of cross-country skiers were found to have EIB. Of the 50 elite summer athletes studied, with and without asthma, Holzer et al found 50% to have EIB. Mannix et al studied 124 elite figure skaters and tested them on an ice rink during their figure-skating routines. Thirty-five percent had a significant postexercise drop in their FEV1. The US Olympic Committee reported an 11.2% prevalence of EIB in all athletes who competed in the 1984 summer Olympics, according to the article "Exercise-Induced Bronchoconstriction in Athletes"1 Elite male athletes, especially competitive swimmers, have an increased risk of wheezing, coughing, and other respiratory symptoms as well as increased risk of asthma, according to Danish researchers who studied 62 athletes. Thomas Lund, MD, from Bispebjerg Hospital in Copenhagen, said more than a third of the athletes studied had respiratory symptoms and 21% had asthma.(2)
The most common therapeutic recommendation for minimizing or preventing symptoms in athletes who have EIB is the prophylactic use of short-acting bronchodilators (ie, ß2-receptor agonists) such as albuterol shortly before exercise. ß2-agonists are considered to be the most effective therapy for the prevention of symptoms of EIB in asthmatic patients. Treatment with two puffs of a short-acting ß2-receptor agonists shortly before (15 min) exercise will provide peak bronchodilation in 15 to 60 min and protection from EIB for at least 3 h in most patients. However, the overuse of ß2-agonists has been shown to result in tachyphylaxis and to worsen symptoms of EIB and asthma.
Many athletes find that a period of precompetition
warm-up reduces the symptoms of EIB that occur during their competitive
activity. Athletes often draw this conclusion without any guidance from
health-care specialists. Symptoms of EIB usually occur after a few minutes
of exercise, and some athletes find that warming up before exercise acts
as prophylaxis against more significant episodes of EIB during exercise. References:
|
||||||||
|
All rights reserved. Please read our Legal Disclaimer and Shipping&Returns Policy. Web-master T.Poretski |
|
||||||||